Private markets entered 2025 with strong momentum, but the first half of the year delivered a reality check as volatility and uncertainty tested investor confidence. Despite this, private markets are positioned for renewed growth heading into 2026.

In recent years, private markets have attracted growing interest from retail investors seeking diversification beyond traditional stocks and bonds. But one of the biggest challenges with private market investments—such as private equity, venture capital, or private real estate—is their inherent illiquidity.

Healthcare professionals often seek alternative investment opportunities beyond public markets to diversify their portfolios and access high-growth potential companies. However, direct investing in private market stock—such as shares offered via Nasdaq Private Market (NPM)—can be complex, requiring accreditation, due diligence, and compliance with regulatory requirements.

Private market investing—spanning venture capital, private equity, private credit, real estate, and other alternative assets—offers accredited investors access to opportunities beyond public markets. However, these investments are complex, illiquid, and opaque

This convergence allows retail investors to access higher-return potential private assets through liquid-ish structures with fees positioned between traditional public and private offerings. The shift represents what McKinsey calls a "great convergence"as alternative managers seek new capital sources beyond institutional investors.

Rising defaults and regulatory concerns are challenging the stability of the $2.5 trillion private credit industry

Discover how a surgeon used private markets investing to improve portfolio diversification, reduce volatility, and enhance long-term returns through private equity, private credit, and real estate.